Advances in pediatric hematopoietic stem cell transplantation

Area of Science:

• Medicine
• Immunology
• Oncology

Background:

• Hematopoietic stem cell transplantation (HSCT) is a vital treatment for various hematologic malignancies, solid tumors, and genetic disorders.
• The increasing application of HSCT necessitates advancements in donor selection and therapeutic strategies.

Purpose of the Study:

• To review recent advances in allogeneic and autologous HSCT.
• To highlight innovations in stem cell sources, graft engineering, conditioning regimens, and supportive therapies.

Main Methods:

• Review of current literature on HSCT advancements.
• Analysis of novel approaches in stem cell sourcing, graft manipulation, and patient conditioning.
• Exploration of emerging immunotherapies and pharmacologic interventions.

Main Results:

• Expanded donor options, including unrelated cord blood and partially matched donors, increase transplant accessibility.
• Graft engineering strategies show promise in mitigating graft-versus-host disease (GVHD) and enhancing graft-versus-leukemia effects.
• Reduced-intensity and non-myeloablative conditioning regimens broaden HSCT applicability to patients with comorbidities.
• Combination therapies involving cytokines and monoclonal antibodies are under investigation to optimize HSCT outcomes.

Conclusions:

• Contemporary HSCT is evolving with diverse stem cell sources and innovative therapeutic strategies.
• Advances in HSCT aim to improve efficacy, reduce toxicity, and expand treatment options for a wider patient population.
• Ongoing research in graft engineering and conditioning regimens holds significant potential for future cellular immune therapies.